Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial.

Ulf-Henrik Mellqvist Mellqvist, Jan Westin, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Inge Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Olle Linder, Hareth NahiIngerid Nesthus, Nielsaage Tøffner Clausen, Raija Silvennoinen, Niels Frost Andersen, Ingemar Turesson, Anders Waage

Research output: Contribution to journalConference abstract in journalResearch

Original languageEnglish
JournalBlood
ISSN0006-4971
Publication statusPublished - 2009
Externally publishedYes
EventASH Annual Meeting -
Duration: 5 Dec 20098 Dec 2009

Conference

ConferenceASH Annual Meeting
Period05/12/200908/12/2009

Cite this